World Intellectual Property Organization

Symposium on Intellectual Property and Life Sciences Regulation

Provisional Program

09.00 – 09.30 Registration
09.30 – 09.40 Opening
  • Mr. Francis Gurry, Deputy Director General, PCT and Patents, Arbitration and Mediation Center, and Global IP Issues, WIPO
  • Dr. Meir Perez Pugatch, University of Haifa & Director of Research Stockholm Network
09.40 – 10.00 Overview of current issues, WIPO perspective
  • Mr. Antony Taubman, Acting Director and Head, Global IP Issues Division, WIPO
  Protection of test data (Chair - Mr. Anthony Taubman)
10.00 – 10.20 Policy and legal choices
  • Dr. Meir P. Pugatch [PDF]
10.20 – 10.40 Development perspective
  • Mr. Christoph Spennemann, Legal Expert, Intellectual Property Team, Policy Implementation Section, Division on Investment, Technology and Enterprise Development, United Nations Conference on Trade and Development [PDF]
10.40 – 11-40 Sectoral perspectives
  • 10.40 – 11.00: Mrs. Maria Souleau, Vice President, Patents France, Sanofi Aventis
  • 11.00 – 11.20: Ms. Suzette Kox, Senior Director Scientific Affairs, European Generic Medicines Association [PDF]
  • 11.20 - 11.40: Ms. Michelle López, Manager, Intellectual Property & Trade, CropLife International [PDF]
11.40 – 12.00 WHO perspective
  • Ms. Karin Timmermanns, Technical Officer, Regional Offices for South-East Asia & Western Pacific, World Health Organization [PDF]
12.00 – 12.30 Discussion
12.30 – 14.00 Lunch break
  (Chair - Dr. Meir P. Pugatch)
14.00 – 14.15 Life Sciences Disputes: the Role of Arbitration and Mediation
  • Mr. Ignacio de Castro Llamas, Deputy Director and Head, Information and External Relations Section, WIPO Arbitration and Mediation Center [PDF]
  Linkages between product regulation and the patent system
14.15 – 14.30 "Bolar" Provisions and the WTO dispute ruling: "Canada – Patent Protection for Pharmaceutical Products"
  • Mr. Roger Kampf, Counsellor, Intellectual Property Division, World Trade Organization [PDF]
14.30 – 15.00 Patent term extensions
  • Ms. Alison Blakey, Patent Counsel & Director IP, Prosidion Limited, Oxford, GB
15.00 – 15.30 Coffee break
  Other linkages between generic entry and patent system
15.30 – 16.00 Biosimilars
  • Marc Markus, Pfizer Brevet, European Patent Department, Paris, France
16.00 – 17.00 Linkages between generic approval and the patent system
  • Ms. Karin Ferriter, Legal Advisor, Office of International Intellectual Property Policy and Enforcement, United States Patent and Trademark Office [ PDF]
  • Ms. Erika Veiga, Manager of International Sanitary Regulations, Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária - ANVISA) [PDF]
17.00 – 17.30 Discussion

Explore WIPO